<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">100939340</journal-id>
<journal-id journal-id-type="pubmed-jr-id">21894</journal-id>
<journal-id journal-id-type="nlm-ta">Traffic</journal-id>
<journal-id journal-id-type="iso-abbrev">Traffic</journal-id>
<journal-title-group>
<journal-title>Traffic (Copenhagen, Denmark)</journal-title>
</journal-title-group>
<issn pub-type="ppub">1398-9219</issn>
<issn pub-type="epub">1600-0854</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28266105</article-id>
<article-id pub-id-type="pmc">5389918</article-id>
<article-id pub-id-type="doi">10.1111/tra.12477</article-id>
<article-id pub-id-type="manuscript">NIHMS858714</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>C9orf72: At the intersection of lysosome cell biology and neurodegenerative disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Amick</surname>
<given-names>Joseph</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ferguson</surname>
<given-names>Shawn M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Cell Biology, Yale University School of Medicine, New Haven, CT, 06510</aff>
<aff id="A2"><label>2</label>Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT, 06510</aff>
<author-notes>
<corresp id="FN1"><label>*</label>To whom correspondence should be addressed: <email>shawn.ferguson@yale.edu</email>, phone: 203-737-5505, fax: 203-737-2065</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>5</month>
<year>2018</year>
</pub-date>
<volume>18</volume>
<issue>5</issue>
<fpage>267</fpage>
<lpage>276</lpage>
<!--elocation-id from pubmed: 10.1111/tra.12477-->
<abstract>
<p id="P1">The discovery that expansion of a hexanucleotide repeat within a non-coding region of the C9orf72 gene causes amyotrophic lateral sclerosis and frontotemporal dementia raised questions about C9orf72 protein function and potential disease relevance. The major predicted structural feature of the C9orf72 protein is a DENN domain. As DENN domains are best characterized for regulation of specific Rab GTPases, it has been proposed that C9orf72 may also act through regulation of a GTPase target. Recent genetic and cell biological studies furthermore indicate that the C9orf72 protein functions at lysosomes as part of a larger complex that also contains the Smith-Magenis Chromosome Region 8 (SMCR8) and WD repeat-containing protein 41 (WDR41) proteins. An important role for C9orf72 at lysosomes is supported by defects in lysosome morphology and mTORC1 signaling arising from C9orf72 KO in diverse model systems. Collectively, these new findings define a C9orf72-containing protein complex and a lysosomal site of action as central to C9orf72 function and provide a foundation for the elucidation of direct physiological targets for C9orf72. Further elucidation of mechanisms whereby C9orf72 regulates lysosome function will help to determine how the reductions in C9orf72 expression levels that accompany hexanucleotide repeat expansions contribute to both normal physiology and disease pathology.</p>
</abstract>
<kwd-group>
<kwd>amyotrophic lateral sclerosis</kwd>
<kwd>frontotemporal dementia</kwd>
<kwd>lysosome</kwd>
<kwd>mTORC1</kwd>
<kwd>neurodegeneration</kwd>
<kwd>C9orf72</kwd>
<kwd>SMCR8</kwd>
<kwd>Birt-Hogg-Dub√© syndrome</kwd>
<kwd>FLCN</kwd>
<kwd>autophagy</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>